Literature DB >> 2550282

Comparison of motility stimulants for cryopreserved human semen.

D G Hammitt1, E Bedia, P R Rogers, C H Syrop, J F Donovan, R A Williamson.   

Abstract

Caffeine, pentoxifylline, 2-deoxyadenosine, cyclic adenosine monophosphate (cAMP), relaxin, adenosine, kallikrein, and calcium were compared for their ability to stimulate motility of cryopreserved sperm. Caffeine, pentoxifylline, and 2-deoxyadenosine significantly increased the percentage of motile sperm at 15, 30, 45, and 60 minutes after administration. Sperm velocity was significantly increased by caffeine at 0, 15, 30, and 45 minutes, and by pentoxifylline at 0, 45, and 60 minutes. Consistent stimulation was not observed for other chemicals. Caffeine, pentoxifylline, and 2-deoxyadenosine were then examined for their ability to provide motility stimulation after removal with washing. With the exception of caffeine, percent motility and velocity for stimulated and untreated sperm were similar after washing. A significant reduction in motility was observed at 48 hours after washing for caffeine. The percentage of hamster oocytes penetrated at 24 hours after washing was significantly reduced for caffeine, 2-deoxyadenosine, and pentoxifylline combined with 2-deoxyadenosine. Pentoxifylline-treated sperm showed no reduction in fertilizing capacity. These results indicate that, of the chemicals examined, pentoxifylline is superior for motility stimulation of cryopreserved sperm.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550282     DOI: 10.1016/s0015-0282(16)60925-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Acetyl-L-carnitine: An effective antioxidant against cryo-damage on human spermatozoa with asthenospermia.

Authors:  Yu-Jie Zou; Jing Yang; Shuo Chang; Wang-Ming Xu; Tai-Lang Yin; Wen Long
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

2.  An evaluation of the effect of pentoxifylline on sperm function and treatment outcome of male-factor infertility: a preliminary study.

Authors:  S Fountain; B Rizk; S Avery; C Palmer; M Blayney; M Macnamee; C Mills; P Brinsden
Journal:  J Assist Reprod Genet       Date:  1995-11       Impact factor: 3.412

3.  Successful use of pentoxifylline in male-factor infertility and previous failure of in vitro fertilization: a prospective randomized study.

Authors:  B Rizk; S Fountain; S Avery; C Palmer; M Blayney; M Macnamee; C Mills; P Brinsden
Journal:  J Assist Reprod Genet       Date:  1995-11       Impact factor: 3.412

Review 4.  Current Insights and Latest Updates in Sperm Motility and Associated Applications in Assisted Reproduction.

Authors:  Reyon Dcunha; Reda S Hussein; Hanumappa Ananda; Sandhya Kumari; Satish Kumar Adiga; Nagarajan Kannan; Yulian Zhao; Guruprasad Kalthur
Journal:  Reprod Sci       Date:  2020-12-07       Impact factor: 3.060

5.  Effects of pentoxifylline on human sperm parameters in vitro.

Authors:  I Mladenovic; S Micic; R M Pearson; O Genbacev; N Papic
Journal:  J Assist Reprod Genet       Date:  1994-11       Impact factor: 3.412

6.  Quinoline Derivative Enhances Human Sperm Motility and Improves the Functional Competence.

Authors:  Sandhya Kumari; Sujith Raj Salian; Arpitha Rao; Shilpa M Somagond; Ravindra R Kamble; Aravind Nesaragi; Jyotirekha Das; G K Rajanikant; Srinivas Mutalik; Shamprasad Varija Raghu; Satish Kumar Adiga; Guruprasad Kalthur
Journal:  Reprod Sci       Date:  2020-11-25       Impact factor: 3.060

7.  Lysophosphatidic Acid Improves Human Sperm Motility by Enhancing Glycolysis and Activating L-Type Calcium Channels.

Authors:  Yinlam Li; Li Jin; Yanquan Li; Jianing Qian; Zhengquan Wang; Xiaoguo Zheng; Chong Xie; Xuelian Zhang; Hefeng Huang; Yuchuan Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

Review 8.  Sperm preparation for ART.

Authors:  Ralf R Henkel; Wolf-Bernhard Schill
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

Review 9.  Male infertility: lifestyle factors and holistic, complementary, and alternative therapies.

Authors:  David F Yao; Jesse N Mills
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.